The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)

Early stages are under-represented in studies on the molecular and immune features of high-grade serous ovarian carcinoma (HGSOC), and specific studies focused on early-stage HGSOC are required for a better prognostic stratification and to personalize chemotherapy. The aim of this study was to deter...

Full description

Bibliographic Details
Authors: Pizarro, David, Romero, Ignacio, Pérez-Mies, Belén, Redondo Sánchez, Andrés|||0000-0002-7257-5642, Caniego-Casas, Tamara, Carretero-Barrio, Irene|||0000-0003-1986-2965, Cristóbal, Eva, Gutiérrez-Pecharromán, Ana, Santaballa, Ana|||0000-0001-7763-320X, D'Angelo, Emanuela|||0000-0002-6173-1806, Hardisson, David|||0000-0002-2183-3699, Vieites, Begoña, Matías-Guiu, Xavier|||0000-0002-7201-6605, Estévez-García, Purificación, Guerra, Eva|||0000-0003-1910-4451, Prat, Jaime|||0000-0002-9787-3304, Poveda, Andrés, López-Guerrero, J.A.|||0000-0002-7369-8388, Palacios, José|||0000-0002-6730-5066
Format: article
Publication Date:2023
Country:España
Institution:Universitat Autònoma de Barcelona
Repository:Dipòsit Digital de Documents de la UAB
Language:English
OAI Identifier:oai:ddd.uab.cat:319576
Online Access:https://ddd.uab.cat/record/319576
https://dx.doi.org/urn:doi:10.3390/ijms241311183
Access Level:Open access
Keyword:High-grade serous ovarian carcinoma
Early stage
PD-L1
BRCA
TMB
id ES_fb52f8ca5ab11cf591bedb60caddf393
oai_identifier_str oai:ddd.uab.cat:319576
network_acronym_str ES
network_name_str España
repository_id_str
spelling The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)Pizarro, DavidRomero, IgnacioPérez-Mies, BelénRedondo Sánchez, Andrés|||0000-0002-7257-5642Caniego-Casas, TamaraCarretero-Barrio, Irene|||0000-0003-1986-2965Cristóbal, EvaGutiérrez-Pecharromán, AnaSantaballa, Ana|||0000-0001-7763-320XD'Angelo, Emanuela|||0000-0002-6173-1806Hardisson, David|||0000-0002-2183-3699Vieites, BegoñaMatías-Guiu, Xavier|||0000-0002-7201-6605Estévez-García, PurificaciónGuerra, Eva|||0000-0003-1910-4451Prat, Jaime|||0000-0002-9787-3304Poveda, AndrésLópez-Guerrero, J.A.|||0000-0002-7369-8388Palacios, José|||0000-0002-6730-5066High-grade serous ovarian carcinomaEarly stagePD-L1BRCATMBEarly stages are under-represented in studies on the molecular and immune features of high-grade serous ovarian carcinoma (HGSOC), and specific studies focused on early-stage HGSOC are required for a better prognostic stratification and to personalize chemotherapy. The aim of this study was to determine the prognostic significance of CD8+ and CD4+ tumor-infiltrating lymphocytes (TILs), tumoral cell PD-L1 expression, BRCA mutational status and tumor mutation burden (TMB) in early-stage HGSOC. A retrospective study was performed on stage I and II HGSOC from the Molecular Reclassification of Early Stages of Ovarian Cancer (RECLAMO) cohort from the Spanish Group of Ovarian Cancer Research (GEICO). Centralized histological typing was performed based on morphological and immunohistochemical features. Intraepithelial (i) and stromal (s) CD8+ and CD4+ T cells and PD-L1 were evaluated on tissue microarrays by immunohistochemistry. BRCA1 and BRCA2 mutation status and TMB were analyzed in tumor DNA using next-generation sequencing. The study included 124 tumors. High iCD8+ (. 22023-01-0120232023-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/319576https://dx.doi.org/urn:doi:10.3390/ijms241311183reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengInstituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI19/01331Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI22/01892Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PMP22/00054Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 CB16/12/00316European Development Regional Fund 'A way to achieve Europe' (FEDER) CB16/12/00316Spanish Group of Research in Ovarian Cancer (GEICO group) CB16/12/00316Spanish Association Against Cancer Scientific Foundation (AECC) CB16/12/00316open accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:3195762026-06-06T12:50:31Z
dc.title.none.fl_str_mv The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
title The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
spellingShingle The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
Pizarro, David
High-grade serous ovarian carcinoma
Early stage
PD-L1
BRCA
TMB
title_short The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
title_full The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
title_fullStr The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
title_full_unstemmed The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
title_sort The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
dc.creator.none.fl_str_mv Pizarro, David
Romero, Ignacio
Pérez-Mies, Belén
Redondo Sánchez, Andrés|||0000-0002-7257-5642
Caniego-Casas, Tamara
Carretero-Barrio, Irene|||0000-0003-1986-2965
Cristóbal, Eva
Gutiérrez-Pecharromán, Ana
Santaballa, Ana|||0000-0001-7763-320X
D'Angelo, Emanuela|||0000-0002-6173-1806
Hardisson, David|||0000-0002-2183-3699
Vieites, Begoña
Matías-Guiu, Xavier|||0000-0002-7201-6605
Estévez-García, Purificación
Guerra, Eva|||0000-0003-1910-4451
Prat, Jaime|||0000-0002-9787-3304
Poveda, Andrés
López-Guerrero, J.A.|||0000-0002-7369-8388
Palacios, José|||0000-0002-6730-5066
author Pizarro, David
author_facet Pizarro, David
Romero, Ignacio
Pérez-Mies, Belén
Redondo Sánchez, Andrés|||0000-0002-7257-5642
Caniego-Casas, Tamara
Carretero-Barrio, Irene|||0000-0003-1986-2965
Cristóbal, Eva
Gutiérrez-Pecharromán, Ana
Santaballa, Ana|||0000-0001-7763-320X
D'Angelo, Emanuela|||0000-0002-6173-1806
Hardisson, David|||0000-0002-2183-3699
Vieites, Begoña
Matías-Guiu, Xavier|||0000-0002-7201-6605
Estévez-García, Purificación
Guerra, Eva|||0000-0003-1910-4451
Prat, Jaime|||0000-0002-9787-3304
Poveda, Andrés
López-Guerrero, J.A.|||0000-0002-7369-8388
Palacios, José|||0000-0002-6730-5066
author_role author
author2 Romero, Ignacio
Pérez-Mies, Belén
Redondo Sánchez, Andrés|||0000-0002-7257-5642
Caniego-Casas, Tamara
Carretero-Barrio, Irene|||0000-0003-1986-2965
Cristóbal, Eva
Gutiérrez-Pecharromán, Ana
Santaballa, Ana|||0000-0001-7763-320X
D'Angelo, Emanuela|||0000-0002-6173-1806
Hardisson, David|||0000-0002-2183-3699
Vieites, Begoña
Matías-Guiu, Xavier|||0000-0002-7201-6605
Estévez-García, Purificación
Guerra, Eva|||0000-0003-1910-4451
Prat, Jaime|||0000-0002-9787-3304
Poveda, Andrés
López-Guerrero, J.A.|||0000-0002-7369-8388
Palacios, José|||0000-0002-6730-5066
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv High-grade serous ovarian carcinoma
Early stage
PD-L1
BRCA
TMB
topic High-grade serous ovarian carcinoma
Early stage
PD-L1
BRCA
TMB
description Early stages are under-represented in studies on the molecular and immune features of high-grade serous ovarian carcinoma (HGSOC), and specific studies focused on early-stage HGSOC are required for a better prognostic stratification and to personalize chemotherapy. The aim of this study was to determine the prognostic significance of CD8+ and CD4+ tumor-infiltrating lymphocytes (TILs), tumoral cell PD-L1 expression, BRCA mutational status and tumor mutation burden (TMB) in early-stage HGSOC. A retrospective study was performed on stage I and II HGSOC from the Molecular Reclassification of Early Stages of Ovarian Cancer (RECLAMO) cohort from the Spanish Group of Ovarian Cancer Research (GEICO). Centralized histological typing was performed based on morphological and immunohistochemical features. Intraepithelial (i) and stromal (s) CD8+ and CD4+ T cells and PD-L1 were evaluated on tissue microarrays by immunohistochemistry. BRCA1 and BRCA2 mutation status and TMB were analyzed in tumor DNA using next-generation sequencing. The study included 124 tumors. High iCD8+ (.
publishDate 2023
dc.date.none.fl_str_mv 2
2023-01-01
2023
2023-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/319576
https://dx.doi.org/urn:doi:10.3390/ijms241311183
url https://ddd.uab.cat/record/319576
https://dx.doi.org/urn:doi:10.3390/ijms241311183
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.relation.none.fl_str_mv Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI19/01331
Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PI22/01892
Instituto de Salud Carlos III https://doi.org/10.13039/501100004587 PMP22/00054
Ministerio de Economía y Competitividad https://doi.org/10.13039/501100003329 CB16/12/00316
European Development Regional Fund 'A way to achieve Europe' (FEDER) CB16/12/00316
Spanish Group of Research in Ovarian Cancer (GEICO group) CB16/12/00316
Spanish Association Against Cancer Scientific Foundation (AECC) CB16/12/00316
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869425318671941632
score 15.811543